Understanding Supraventricular Tachycardia: Causes and Effects
Supraventricular tachycardia (SVT) involves an abnormally rapid heart rate originating above the ventricles. The described mechanism—shortened AV nodal conduction after vagal blockade with increased sinus rate—reflects one pathophysiological pathway. When heart rate exceeds ~150 bpm, ventricular filling time becomes insufficient, reducing stroke volume and ejection volume despite increased contractility (positive inotropy). Mean arterial pressure rises due to elevated heart rate. This hemodynamics can cause symptoms like palpitations, dizziness, shortness of breath, and chest discomfort. SVT requires ECG confirmation and may be managed with vagal maneuvers, medications (adenosine, beta-blockers, calcium channel blockers), or catheter ablation.
Cardiovascular Disease - Related Articles
- Arterial Supply to the Ribs and Thoracic Wall: Anatomical Overview
- Becoming a Cardiovascular Perfusionist: Education & Requirements
- Cardiac Recovery Time: Why Athletes Recover Faster Than Sedentary Individuals
- Heart Health: Diet and Exercise Strategies to Lower Cardiovascular Risk
- The Heart and Blood Vessels: How the Circulatory System Works
- Understanding and Managing Congestive Heart Failure (CHF)
- Arrhythmia vs. Fibrillation: Definitions and Differences
